These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 24110348)

  • 1. Localization of brachytherapy seeds in MRI by deconvolution.
    Dong Y; Chang Z; Whitehead G; Ji J
    Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():2960-3. PubMed ID: 24110348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility-based positive contrast MRI of brachytherapy seeds.
    Dong Y; Chang Z; Xie G; Whitehead G; Ji JX
    Magn Reson Med; 2015 Sep; 74(3):716-26. PubMed ID: 25251865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive contrast MRI of prostate brachytherapy seeds by susceptibility mapping.
    Dong Y; Ji J
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():392-5. PubMed ID: 23365912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI-based automated detection of implanted low dose rate (LDR) brachytherapy seeds using quantitative susceptibility mapping (QSM) and unsupervised machine learning (ML).
    Nosrati R; Soliman A; Safigholi H; Hashemi M; Wronski M; Morton G; Pejović-Milić A; Stanisz G; Song WY
    Radiother Oncol; 2018 Dec; 129(3):540-547. PubMed ID: 30243670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated susceptibility-based positive contrast imaging of MR compatible metallic devices based on modified fast spin echo sequences.
    Shi C; Xie G; Zhang Y; Zhang X; Chen M; Su S; Dong Y; Liu X; Ji J
    Phys Med Biol; 2017 Apr; 62(7):2505-2520. PubMed ID: 28182582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging and localizing interventional devices by susceptibility mapping using MRI.
    Dong Y; Chang Z; Ji J
    Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():1541-4. PubMed ID: 25570264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating platinum coated brachytherapy seeds and gold fiducial markers with varying off-resonant frequency offsets.
    McNabb E; Wong R; Noseworthy MD
    Magn Reson Imaging; 2019 Jul; 60():68-75. PubMed ID: 30959177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of an MRI-only workflow for postimplant dosimetry of low-dose-rate prostate brachytherapy: Transition from phantoms to patients.
    Nosrati R; Song WY; Wronski M; Pejović-Milić A; Morton G; Stanisz GJ
    Brachytherapy; 2019; 18(6):863-874. PubMed ID: 31337542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive contrast MRI of prostate brachytherapy seeds based on resonant frequency offset mapping.
    Whitehead G; Ji J
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():6641-4. PubMed ID: 21096732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in MR-only seed localization for postimplant dosimetry in permanent prostate brachytherapy.
    Zijlstra F; Moerland MA; van der Voort van Zyp JRN; Noteboom JL; Viergever MA; Seevinck PR
    Med Phys; 2017 Oct; 44(10):5051-5060. PubMed ID: 28777451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI of prostate brachytherapy seeds at high field: a study in phantom.
    Thomas SD; Wachowicz K; Fallone BG
    Med Phys; 2009 Nov; 36(11):5228-34. PubMed ID: 19994533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of brachytherapy seeds using 3-D transrectal ultrasound.
    Wen X; Salcudean ST; Lawrence PD
    IEEE Trans Biomed Eng; 2010 Oct; 57(10):2467-77. PubMed ID: 20595088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the susceptibility artifact around a prostate brachytherapy seed in MRI.
    Wachowicz K; Thomas SD; Fallone BG
    Med Phys; 2006 Dec; 33(12):4459-67. PubMed ID: 17278797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential applications of the quantitative susceptibility mapping (QSM) in MR-guided radiation therapy.
    Nosrati R; Paudel M; Ravi A; Pejovic-Milic A; Morton G; Stanisz GJ
    Phys Med Biol; 2019 Jul; 64(14):145013. PubMed ID: 31151120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated positive contrast MRI of interventional devices using parallel compressed sensing imaging.
    Vafay Eslahi S; Ji J
    Magn Reson Imaging; 2019 Jul; 60():130-136. PubMed ID: 31028791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy.
    Sanders JW; Song H; Frank SJ; Bathala T; Venkatesan AM; Anscher M; Tang C; Bruno TL; Wei W; Ma J
    Brachytherapy; 2018; 17(5):816-824. PubMed ID: 29880449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pulse sequence parameter selection on signal strength in positive-contrast MRI markers for MRI-based prostate postimplant assessment.
    Lim TY; Kudchadker RJ; Wang J; Stafford RJ; MacLellan C; Rao A; Ibbott GS; Frank SJ
    Med Phys; 2016 Jul; 43(7):4312. PubMed ID: 27370146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy.
    Ali I; Algan O; Thompson S; Sindhwani P; Herman T; Cheng CY; Ahmad S
    Phys Med Biol; 2009 Sep; 54(18):5595-611. PubMed ID: 19717887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CT- and MRI-based seed localization in postimplant evaluation after prostate brachytherapy.
    De Brabandere M; Al-Qaisieh B; De Wever L; Haustermans K; Kirisits C; Moerland MA; Oyen R; Rijnders A; Van den Heuvel F; Siebert FA
    Brachytherapy; 2013; 12(6):580-8. PubMed ID: 23876358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate brachytherapy seed localization by analysis of multiple projections: identifying and addressing the seed overlap problem.
    Su Y; Davis BJ; Herman MG; Robb RA
    Med Phys; 2004 May; 31(5):1277-87. PubMed ID: 15191320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.